Go Pro
OTCMKTS:ISCNF

Isracann Biosciences (ISCNF) Stock Price, News & Analysis

Isracann Biosciences logo

About Isracann Biosciences Stock (OTCMKTS:ISCNF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
700 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Isracann Biosciences Ltd. (OTCMKTS:ISCNF) is an Israel-based biotechnology company specializing in the research, breeding, production and distribution of medical-grade cannabis. The firm operates a purpose-built cultivation and processing facility where it develops proprietary cannabis cultivars designed to address specific therapeutic needs. Its research and development efforts focus on optimizing cannabinoid profiles, enhancing cultivation yields and ensuring compliance with pharmaceutical-grade production standards.

The company holds cultivation and export licenses issued by the Israeli Ministry of Health, enabling it to supply medical cannabis products to patients under Israel’s regulated program. In addition to serving the domestic market, Isracann is pursuing regulatory approvals and strategic partnerships to address select international markets. Through its integrated model, the company seeks to advance novel cannabis-based therapies while maintaining rigorous quality control and traceability across its product portfolio.

AI Generated. May Contain Errors.

Receive ISCNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isracann Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISCNF Stock News Headlines

Isracann Biosciences
Major Buy Alert Issued for August 31st
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of August 31st. See which stocks his AI research platform is flagging right now.tc pixel
Elevai Biosciences engages KCRN Research to support IND efforts for EL-22
MBX Biosciences Inc
IIROC Trading Halt - IPOT
Isracann Biosciences Inc. (ISCNF)
See More Headlines

ISCNF Stock Analysis - Frequently Asked Questions

Shares of ISCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ISCNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:ISCNF) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners